Scientists have developed a simple method of extracting tiny biological particles from a person's blood and use them as biomarkers to assess the health of their blood vessels.
Engineers have unveiled an air-powered computer memory that can be used to control soft robots. It overcomes the problem of the mismatch between pneumatics and electronics.
With a ‘liquid assembly line,’ researchers produce mRNA-delivering-nanoparticles a hundred times faster than standard microfluidic technologies.
Progressive Mechanoporation makes it possible to mechanically disrupt the membranes of cells for a short time period and let drugs or genes inside cells.
Researchers have developed an “organs-on-a-chip” system that replicates interactions between the brain, liver, and colon.
Researchers have demonstrated a novel multifunctional ultrathin contact lens sensor layer with transistors that may revolutionise the manufacture of smart contact lenses.
Researchers have invented a high-throughput cell separation method that can be used in conjunction with droplet microfluidics.
The supplier sector will showcase its expertise and innovative high-tech solutions for the medical technology industry.
Scientists have developed a bioelectronic system driven by a machine learning algorithm that can shift the membrane voltage in living cells and maintain it at a set point for 10 hours.
Xsensio has been awarded CHF 1.8 million in EU funding to adapt its Lab-on-Skin sensing patches so that they can detect when a viral illness like the flu or COVID-19 is about to get worse.
Since mid-2019, the Fraunhofer IBMT has been developing an analysis platform as an alternative to animal experiments in drug development.
EPFL spin-off Annaida is developing a magnetic resonance system that can detect the chemistry inside the tiniest living organisms.